Gosset YAFO Capital General Information
YAFO Capital is a leading Shanghai-based boutique investment and advisory firm focused on the healthcare and life sciences sectors. Founded in 2013, it specializes in cross-border transactions—particularly licensing deals—between global pharma/biotech companies and China/Asia. The firm operates through two main divisions (YAFO Life Sciences for advisory/investment banking services and YAFO Fund Management for direct investments) and has been ranked as the top advisor for China cross-border licensing transactions over the past several years. It also organizes major partnering events such as ACCESS CHINA to facilitate deal-making between Western innovators and Asian partners.
Contact Information
China
Drug Pipeline
No pipeline data available
Key Partnerships
Outcome Capital (strategic partnership announced September 2023 to expand global financial/life science advisory services)
YAFO Capital Funding
No funding data available